- High throughput: Screens the central nervous system (CNS) activity of numerous compounds and accurately identifies compounds with phenotypic characteristics effective for the treatment of neuropsychiatric diseases.
- High content: Uses proprietary machine learning algorithms to detect subtle phenotypic differences that are usually undetectable through standard tests.
- High precision: Employs computer vision and artificial intelligence to eliminate human intervention and associated subjectivity.
